Director, Global Regulatory Lead

Curium Pharma; United States; On-site; USD 180,000 - 260,000; Full time

Job summary

Curium in the United States is seeking a Director, Global Regulatory Lead to provide global regulatory leadership for oncology radiopharmaceutical programs. You will develop and execute strategies supporting development from early clinical to registration and lifecycle management.

The role requires extensive experience across both early- and late-stage development, IND/CTA strategy, global Health Authority interactions, and NDA/BLA submissions.

Qualifications

• 10+ years of Regulatory Affairs experience within pharma/biotech oncology drug development.
• Experience as global regulatory lead on cross-functional program teams.
• Experience from early clinical through product registration.
• Experience leading FDA and international Health Authority interactions.
• Experience leading major global regulatory submissions.

Responsibilities

• Lead development and execution of global regulatory strategies for oncology radiopharmaceutical programs.
• Serve as Global Regulatory Lead on cross-functional program teams; develop regulatory strategy and contribute to program plans.
• Oversee global regulatory submissions (IND, CTAs, NDA/BLA) and interactions with health authorities.
• Identify regulatory risks and opportunities and provide mitigation strategies.
• Ensure alignment of global regulatory strategy across US, EU, UK, Canada, Australia, Japan and other markets.

Skills

Global regulatory leadership

Oncology regulatory

Cross-functional leadership

IND/CTA strategy

Education

PhD, MD, PharmD or equivalent

Bachelor’s in life sciences

Job description

The Group Curium is the world’s largest nuclear medicine company with over 1,2+ B € revenues. At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 15 million patients annually. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. As a fast-growing company in a niche market, Curium is today owned by a private equity fund with LBO financing scheme.

Building on its unique strengths across radiopharmaceutical product manufacturing, logistics and commercialization, and led by an agile, LBO-driven leadership team, Curium has already achieved a critical mass and is the largest player in the nuclear medicines field. This is one that has become increasingly dynamic and innovative in recent years.

SUMMARY OF POSITION

The Director, Global Regulatory Lead (GRL) will provide global regulatory leadership for one or more oncology programs focused on radiopharmaceutical/nuclear medicine therapeutics. This individual will develop and execute innovative global regulatory strategies supporting products from early clinical development through registration and lifecycle management.

The successful candidate will serve as the Global Regulatory Lead for multidisciplinary development teams, partnering closely with Clinical Development, CMC, Nonclinical, Medical, Biostatistics, Quality, Biometrics, and Commercial to accelerate development while ensuring compliance with global regulatory requirements.

The ideal candidate possesses extensive experience across both early- and late-stage drug development, including IND/CTA strategy, global Health Authority interactions, registration planning, and lifecycle management for oncology products. Experience with radiopharmaceuticals is strongly preferred.

ESSENTIAL FUNCTIONS

Primary Responsibilities

Global Regulatory Strategy

• Lead development and execution of global regulatory strategies for oncology programs.
• Serve as Global Regulatory Lead on cross-functional program teams. Develop comprehensive regulatory strategy and provide inputs to integrated program plans.
• Lead Global Regulatory Team and submission team accountable for delivering global program milestones.
• Develop regulatory pathways supporting development and commercialization.
• Identify regulatory risks and opportunities and recommend mitigation strategies.
• Lead meetings with health authorities, prepare briefing documents and lead cross-functional preparation for agency interactions.
• Ensure alignment of global regulatory strategy across US, EU, UK, Canada, Australia, Japan, and other key markets.
• Oversee the preparation and review of global regulatory submissions, including IND, CTAs, IND amendments, Annual reports, NDA/ BLA, etc.
• Monitor regulatory intelligence and Translate regulatory intelligence into actionable development strategies.

REQUIREMENTS

Education

• PhD, PharmD, MD, MS, or equivalent scientific degree preferred
• Bachelor’s degree in life sciences required

Experience required

• 10+ years of Regulatory Affairs experience within the pharmaceutical or biotechnology industry in oncology drug development
• Demonstrated experience as global regulatory lead, leading global regulatory strategy as part of cross functional program team
• Experience spanning early clinical through product registration
• Experience leading FDA and international Health Authority interactions
• Experience leading major global regulatory submissions

Preferred:

• Radiopharmaceutical or nuclear medicine therapeutic experience
• Targeted radionuclide therapy experience

Ideal Candidate Profile:

The ideal candidate combines deep regulatory expertise with oncology development experience and has successfully led programs from IND/CTA through NDA/BLA or MAA approval. They are comfortable navigating the unique scientific and regulatory challenges associated with targeted radiopharmaceuticals, including dosimetry, isotope manufacturing, companion diagnostics, and accelerated development pathways. They are recognized as a strategic partner capable of influencing senior leadership while effectively collaborating across global, multidisciplinary teams.